Top

Intent to Announce - Request for Prototype Proposals under Medical Countermeasure Systems Other Transaction Agreement

Active

W15QKN-16-Z-05SMFederal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

The announcement serves as an advanced notification to industry and members of the National Chemical and Biological Defense Consortium (NCBDC) regarding the Government’s intent to issue two upcoming Requests for Prototype Proposals (RPP1 and RPP2) for Medical Countermeasure Systems research and development projects. This notice is for planning purposes only and does not constitute a solicitation or award. The Government has previously entered into an Other Transaction Agreement (OTA) with the NCBDC to support prototype development, and it intends to award projects to consortium members through the forthcoming RPP process. The anticipated projects cover a range of medical countermeasure efforts, including the development of monoclonal antibody countermeasures against botulinum toxin, fill/finish processes for Venezuelan Equine Encephalitis virus-like particle products, and next-generation drug delivery devices. Specifically, the seven projects to be solicited are divided between RPP1 and RPP2: RPP1 focuses on monoclonal antibody development and bulk drug product manufacturing, while RPP2 addresses vaccine formulation, clinical studies, and efficacy testing related to equine encephalitis viruses and treatments involving Pyridostigmine Bromide. Participation in these projects requires membership in the NCBDC, and interested parties are encouraged to contact consortium representatives for more information. The opportunity is managed by the Department of Defense at Picatinny Arsenal, NJ, with a designated point of contact provided for inquiries. This announcement aligns with NAICS Code 541330 and aims to leverage collaboration within the NCBDC for advancing critical medical countermeasure technologies.

General Info

Government plans two Requests for Prototype Proposals for NCBDC medical countermeasure projects.

Agency

Department Of Defense → W6QK Acc-Pica

NAICS

541330 - Engineering Services

Place of Performance

Set-Aside

NONE

Documents

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PostedJun 1

special-notice

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

AgencyDepartment Of Defense → W6QK Acc-Pica

Contacts1 person available

OfficePICATINNY ARSENAL, NJ, 07806-5000, USA

Organization / AgencyDepartment Of Defense → W6QK Acc-Pica

Office AddressPICATINNY ARSENAL, NJ, 07806-5000, USA

Contacts

Kristen Kachur

contact@example.gov

+1 (555) 000-0000

Full Description

This is not a Request for Prototype Proposals, but for planning purposes only. A project award will not be awarded from this announcement. The Government intends to announce two Request for Prototype Proposals (RPP1 & RPP2) for execution of a project award(s) in support of Medical Countermeasure Systems Research and Development related to specified project requirements. The purpose of this announcement is to provide members of the National Chemical and Biological Defense Consortium, and industry in general, advanced notification of Government intent. On 08 April 2016, the Government entered into an Other Transaction Agreement (OTA) with one (1) consortium, the National Chemical and Biological Defense Consortium (NCBDC), in support of Medical Countermeasure Systems related research and development prototype projects. It is the intent of the Government to make project award(s) to member(s) of the NCBDC as a result of member project proposals submitted via the Request for Prototype Proposals process. The Government anticipates seven (7) projects to be solicited via W15QKN-16-9-1002-RPP1 & RPP2, consisting of the following: RPP1 1. Development of Monoclonal Antibody Medical Countermeasures against Aerosolized Botulinum Toxin Serotypes A and B 2. Fill/Finish of Venezuelan Equine Encephilits (VEE) virus like particles (VLP) Bulk Drug Product RPP2 1. Development of a Dual Drug Delivery Device (D4) 2. Lyophilized Formulation and Final Product Manufacturing Process for Western/Eastern/Venezuelan Equine Encephilitis (WEVEE) Vaccine 3. VEE Monovalent VLP Phase 1 Clinical Study 4. Eastern Equine Encephilitis Vaccine (EEEV) Prototypes 5. Definitive Efficacy Studies (2) of Pyridostigmine Bromide (PB) In order to obtain more information regarding the above projects, you must be a member of the National Chemical and Biological Defense Consortium (NCBDC), http://ncbdconsortium.org. For more information regarding membership or general questions to the NCBDC, contact Michael Stebbins, at +1 (555) 000-0000 or contact@example.gov.